BioAtla (BCAB) Operating Leases (2021 - 2026)

BioAtla (BCAB) has reported Operating Leases for 6 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 18.07% year-over-year to $4.3 million; the trailing twelve-month figure through Jun 2026 stood at $4.3 million (down 18.07% YoY), and the FY2025 full-year result was $4.8 million, up 2611.93% from the prior year.
• Operating Leases declined to $4.3 million in Q2 2026 per BCAB's latest filing, from $4.5 million in the prior quarter.
• Across five years, Operating Leases topped out at $5.2 million in Q2 2025 and bottomed at $176000.0 in Q4 2024.
• Historically, Operating Leases has averaged $2.8 million across 5 years, with a median of $2.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Leases plunged 79.88% in 2024, then soared 2611.93% in 2025.
• Over 5 years, Operating Leases stood at $2.5 million in 2022, then tumbled by 66.02% to $836000.0 in 2023, then plunged by 78.95% to $176000.0 in 2024, then soared by 2611.93% to $4.8 million in 2025, then retreated by 10.06% to $4.3 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $4.3 million, $4.5 million, and $4.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.